Notify me when Explore Investments LLC/DE files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| LYEL | Lyell Immunopharma, Inc. | Common Stock, par value $0.0001 per share | 5.4% | $9,202,122 | 1,040,964 | Explore Investments LLC | 25 Jul 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|